about
Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment CriteriaGlobal impact of RNA splicing on transcriptome remodeling in the heartTargeting S100A1 in heart failureGene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failureMyocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndromemicroRNAs in heart disease: putative novel therapeutic targets?Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure.Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction.Epigenetic mechanisms in heart failure pathogenesisBlood gene expression signatures associate with heart failure outcomes.Vinculin and talin: focus on the myocardiumTetralogy of Fallot and Hypoplastic Left Heart Syndrome - Complex Clinical Phenotypes Meet Complex Genetic NetworksPharmacoepigenetics in heart failure.Experimental biomarkers in heart failure: an update.Lamins at the crossroads of mechanosignalingIn search of novel targets for heart disease: myocardin and myocardin-related transcriptional cofactors.Heart failure-associated changes in RNA splicing of sarcomere genes.Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression.
P2860
Q26797153-046FDF76-791B-4898-90B2-E5668231AAA7Q26859601-4300F791-35AE-46A7-9C72-330D56043A20Q28259868-792596C7-3808-4DF1-84A0-20F3BB850B6FQ28262080-71D71D7E-97F1-4EDD-9715-A043911316A6Q28732385-0439957B-B40B-4F80-8B9C-479930474CD1Q33728265-1E021BD2-1220-4BB1-9380-4B11F138C99FQ34034976-8346CCD9-EAB8-46AC-923D-EA67487BA334Q34089713-486265EF-49FF-48EA-93CA-4A3DD3E7BECDQ34212728-52D7A798-F2A5-49EA-BC0C-D01EF74FEBEDQ34973559-402691F3-F6F4-40B6-925F-B04B8C67CE1EQ35015533-383C48FF-B9F7-4B4C-866B-D85F0A2C45C9Q35697680-91D7FBD8-C176-484F-A506-F0BCDF98A54CQ37738083-4B249C2D-5AF2-4773-A26A-12B112C62EA5Q38055505-24C875ED-942D-4501-8C57-D713580FD7C5Q38341565-9F9D34E8-CEA6-4A61-8F65-9B9953746FD7Q42180878-BB0FAF93-251C-440C-8AD9-42D2ED297271Q42713273-932E2895-E435-4BDD-9999-61BD39DEC4BAQ46539324-8DC4645A-D1B3-4FBF-8EDF-33A68E0B016EQ54223894-B4C7F0B3-484B-4738-8DF4-F83FAFC06D03
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomics, transcriptional profiling, and heart failure.
@en
Genomics, transcriptional profiling, and heart failure.
@nl
type
label
Genomics, transcriptional profiling, and heart failure.
@en
Genomics, transcriptional profiling, and heart failure.
@nl
prefLabel
Genomics, transcriptional profiling, and heart failure.
@en
Genomics, transcriptional profiling, and heart failure.
@nl
P2093
P2860
P1476
Genomics, transcriptional profiling, and heart failure.
@en
P2093
Daniel L Dries
Daniel P Bednarik
Kenneth B Margulies
P2860
P304
P356
10.1016/J.JACC.2008.12.064
P407
P577
2009-05-01T00:00:00Z